| Financial Year |
March 31 2023 |
| Monetary Funds |
440,240,971.36 |
| Held-for-trading Financial Assets |
12,043,329.29 |
| Notes Receivable |
-- |
| Accounts Receivable |
26,233,372.35 |
| Advances to Suppliers |
34,767,200.85 |
| Other Receivables |
42,908,186.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
77,510,391.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,984,555.98 |
| Total Current Assets |
648,181,628.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
150,279,611.70 |
| Investment Properties |
-- |
| Fixed Assetes |
397,895,906.57 |
| Under-construction Projects |
205,616,553.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
158,924,906.91 |
| R&D expenses |
-- |
| Goodwill |
378,018,688.85 |
| Long-Term Deferred and Prepaid Expenses |
4,897,211.42 |
| Deferred Income Tax Assets |
848,549.84 |
| Other Non-Current Assets |
19,344,476.50 |
| Sub-Total of Non-Current Assets |
1,352,483,375.63 |
| Total Assets |
2,000,665,004.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
93,509,447.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,756,852.69 |
| Taxes Payable |
6,124,184.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,066,004.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,931,637.73 |
| Other Current Liabilities |
2,272,671.16 |
| Sub-Total of Current Liabilities |
225,619,495.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,421,293.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,984,732.18 |
| Total Liabilities |
261,604,227.24 |
| Paid-In Capital(Or Share Stock) |
372,514,005.00 |
| Capital Surplus |
888,985,979.53 |
| Surplus Reserve |
112,454,227.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
355,254,897.85 |
| Minority Stockholder's Interest |
9,851,667.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,729,209,109.40 |
| Owner's Equity（Stockholder's Equity） |
1,739,060,777.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,000,665,004.28 |
